Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04510961
Status:
COMPLETED
Last Update Posted:
2020-08-12
First Post:
2020-08-11
Brief Title:
Paraffin Bath Therapy for Chronic Hand Eczema
Sponsor:
Cairo University
Organization:
Cairo University
Study Overview
Official Title:
Beneficial Effects of Paraffin Bath Therapy as Additional Treatment of Chronic Hand Eczema A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2020-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective Chronic Hand eczema CHE is a common inflammatory skin disease has a major medical psychological and socio-economic implications that affect quality of life QoLand work ability This study the first randomized controlled trial that will be conducted to evaluate the effect of paraffin bath therapy PBT in the treatment of CHE
Detailed Description:
Design The study design is a randomized controlled trial with measures at pre-and post-intervention
Subjects Sixty patients with moderate to severe Chronic Hand eczema CHE will participate in the study They will be classified randomly into two groups of equal number paraffin group and the control group
Interventions Paraffin group will receive Paraffin bath therapy for 5 days per week for 12 weeks in addition to routine skin care program while the control group will receive routine skin care program
Outcome Measures
Objective SCORing Atopic Dermatitis subjective item score and dermatology life quality index DLQI will be assessed before at 6th week and at 12th week of treatment
Subjects Sixty patients with moderate to severe Chronic Hand eczema CHE will participate in the study They will be classified randomly into two groups of equal number paraffin group and the control group
Interventions Paraffin group will receive Paraffin bath therapy for 5 days per week for 12 weeks in addition to routine skin care program while the control group will receive routine skin care program
Outcome Measures
Objective SCORing Atopic Dermatitis subjective item score and dermatology life quality index DLQI will be assessed before at 6th week and at 12th week of treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None